Assistant Professor, Medicine, Brown University Program in Medicine
Infectious Disease
Dr. Awewura Kwara, MD
|
|
Give Review
Awewura Kwara, MD is an expert in the field of Infectious Disease. He went to University of Ghana Medical School. Dr. Awewura Kwara is a published physician. He published 29 publications, including: 'Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.' Awewura Kwara accepts Medicare payments and is registered with Medicare.gov.
Publications
- Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy Through Mechanism-based Inactivation of CYP2A6.
- Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
- Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance.
- Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
- Factors associated with recently transmitted Mycobacterium tuberculosis strain MS0006 in Hinds County, Mississippi.
- Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana.
- Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteers.
- Outcome of hospital admissions in HIV-infected children at the Korle Bu Teaching Hospital, Accra, Ghana.
- Highly active antiretroviral therapy and employment status in accra, ghana.
- High Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic.
- Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
- Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island.
- Paradoxically elevated efavirenz concentrations in HIV/tuberculosis-coinfected patients with CYP2B6 516TT genotype on rifampin-containing antituberculous therapy.
- Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all.
- CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.
- Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated ...
- CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
- Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation.
- Status epilepticus resulting from severe efavirenz toxicity in an HIV-infected patient.
- Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
- Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
- Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection.
- Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
- Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
- Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates.
- Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia.
- Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.
- Delayed entry to care by men with HIV infection in Kumasi, Ghana.
Schools
University of Ghana Medical School
Cook Co Hospital
Tulane University Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Tulane University -
John H. Stroger Hospital of Cook County -
University of Ghana Medical School
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1679538110 | |
| NPPES Provider LastName | KWARA | |
| NPPES Provider FirstName | AWEWURA | |
| NPPES Provider ZIPCode | 029062853 | |
| NPPES Provider State | RI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 298.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679538110 |
| Last Name Of The Provider | KWARA |
| First Name Of The Provider | AWEWURA |
| View All |
Similar Doctors
|
|
Dr. Amanda J. Noska, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Josiah D. Rich, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leonard A. Mermel, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Sajeev Handa, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dalilia A. Zachary, MD |
|
|
Dr. Anne De Groot, MD |
|
|
Dr. Joseph I. Harwell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Timothy P. Flanigan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Staci A. Fischer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa M. Gaitanis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan R. Tunkel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charlene Flash, MD
This Doctor is OpenDoctor Recommended.
|